ArticleScientific reports2025
Impact of excessive hypercholesterolemia in pregnancy on the placentas of the male and female offspring.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Excessive hypercholesterolemia (eHC) in pregnancy reduces placental efficiency in both fetal sexes, but the mechanisms are not known. In this study, Sprague Dawley rats received a control or high cholesterol diet (to model eHC) during pregnancy, after which various markers of placental function were assessed. Lipid levels, but not reactive oxygen species levels, were increased in both the male and female eHC placentas vs. controls. However, compared to control placentas, eHC reduced cholesterol receptors, increased cholesterol transporters, lowered fetal cholesterol levels, and altered the unfolded protein response in a sex-specific manner. Moreover, NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) levels were increased in only the male eHC placentas, and associated with reduced interleukin 1β levels, likely due to its rapid secretion into the circulation. The levels of caspase 8, but not caspase 1, were increased in only the male eHC placentas vs. controls, suggesting that the processing of interleukin 1β may have happened via a non-canonical pathway. In conclusion, eHC in pregnancy impacts the placentas of both the male and female offspring, but the activation of the NLRP3 inflammasome in only the male placentas suggests that the male offspring may be more susceptible to excessive increases in maternal cholesterol levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.